Want to join the conversation?
$CVS's 3Q15 adjusted EPS increase 12.5% YoverY to a $1.29, coming in at the higher of its previously provided guidance range. During the reported quarter excluding acquisition-related transaction and integration costs, operating profit in the $CVS's Retail Long-Term Care business increased 8.4% while that of Pharmacy Services segment increased 7%.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.